135727-85-4

Basic information

• Product Name: N²-[(1,1-dimethylethoxy)carbonyl]-N⁶-[(phenylmethoxy)carbonyl]-L-lysine 1,1-dimethylethyl ester
• Synonyms: N²-[(1,1-dimethylethoxy)carbonyl]-N⁶-[(phenylmethoxy)carbonyl]-L-lysine 1,1-dimethylethyl ester
• CAS NO: 135727-85-4
• Molecular Weight: 436.549
• Mol File: 135727-85-4.mol
• Article Data: 21

Chemical Properties

• CAS DataBase Reference: N²-[(1,1-dimethylethoxy)carbonyl]-N⁶-[(phenylmethoxy)carbonyl]-L-lysine 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N²-[(1,1-dimethylethoxy)carbonyl]-N⁶-[(phenylmethoxy)carbonyl]-L-lysine 1,1-dimethylethyl ester(135727-85-4)
• EPA Substance Registry System: N²-[(1,1-dimethylethoxy)carbonyl]-N⁶-[(phenylmethoxy)carbonyl]-L-lysine 1,1-dimethylethyl ester(135727-85-4)

Safety Data

• Hazardous Substances Data: 135727-85-4(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 5978-22-3 N(ε)-benzoyloxycarbonyl-L-lysine tert-butyl ester hydrochloride 
• 98946-18-0 tert-Butyl 2,2,2-trichloroacetimidate 
• 86060-82-4 Fmoc-Lys(Z)-OH 
• 63628-63-7 Nε-benzyloxycarbonyl-L-lysine tert-butyl ester 
• 71432-55-8 2-tert-butyl-1,3-diisopropylisourea 
• 2389-45-9 Boc-Lys(Z)-OH 
• 75-65-0 tert-butyl alcohol 
• 501-53-1 benzyl chloroformate 
• 13734-28-6 Boc-Lys-OH 
• 1155-64-2 N₆-[(benzyloxy)carbonyl]-L-lysine 
• 507-19-7 t-butyl bromide 

Downstream Products

• 1167421-25-1 (2S)-2-amino-6-{[(2-azidoethoxy)carbonyl]amino}hexanoic acid 
• 205379-08-4 N^α,N^α-bis[(tert-butyloxycarbonyl)methyl]-L-lysine tert-butyl ester 
• 189280-04-4 (2S,9R)-7-Benzyl-2-[(tert-butoxycarbonyl)amino]-10-cyano-9-hydroxy-7-azadecanoic Acid tert-Butyl Ester 
• 189279-99-0 (S)-6-[Benzyl-((S)-3-chloro-2-hydroxy-propyl)-amino]-2-tert-butoxycarbonylamino-hexanoic acid tert-butyl ester 
• 189279-95-6 (S)-t-Boc-Lys(Bz)-O-t-Bu 
• 214051-65-7 (2S,9S)-2-[(tert-Butoxycarbonyl)amino]-7-(carbobenzyloxy)-10-cyano-9-hydroxy-7-azadecanoic Acid tert-Butyl Ester 
• 214051-64-6 (S)-6-[Benzyloxycarbonyl-((R)-3-cyano-2-hydroxy-propyl)-amino]-2-tert-butoxycarbonylamino-hexanoic acid tert-butyl ester 
• 214051-63-5 (2S,9R)-2-[(tert-Butoxycarbonyl)amino]-7-(carbobenzyloxy)-10-chloro-9-hydroxy-7-azadecanoic Acid tert-Butyl Ester 
• 214051-62-4 (2S,9S)-2-[(tert-Butoxycarbonyl)amino]-7-(carbobenzyloxy)-10-chloro-9-hydroxy-7-azadecanoic Acid tert-Butyl Ester 
• 214051-69-1 (2S,9S)-11-[(Benzyloxycarbonyl)amino]-2-[(tert-butoxycarbonyl)amino]-9-hydroxy-7-(carbobenzyloxy)-7-azaundecanoic Acid tert-Butyl Ester 
• 189280-15-7 tert-butyl(2S,9R)-11-[(benzyloxycarbonyl)amino]-2-[(tert-butoxycarbonyl)amino]-9-hydroxy-7-(benzyloxycarbonyl)-7-azaundecanoate 
• 1027089-85-5 (S)-3-Methyl-2-{(S)-2-[(S)-6-nitro-2-(2-trimethylsilanyl-ethoxycarbonylamino)-hexanoylamino]-3-phenyl-propionylamino}-butyric acid methyl ester 
• 63628-63-7 Nε-benzyloxycarbonyl-L-lysine tert-butyl ester 

Relevant articles and documents

Short self-assembling peptides with a urea bond: A new type of supramolecular peptide hydrogel materials

There is an increasing need to develop short self-assembling peptides (SAPs) that can form hydrogels for cell engineering and biomedical applications. In this study, we proposed new short self-assembling peptides with a symmetric structure via a urea bond

Synthesis and evaluation of macrocyclic amino acid derivatives for tumor imaging by gallium-68 positron emission tomography

68Ga PET imaging in clinical oncology represents a notable development because the availability of 68Ga is not dependent on a cyclotron. Furthermore, labeled amino acid derivatives have been proven to be useful for the imaging many t

Synthesis of the unnatural amino acid Nα-Nε-(ferrocene-1-acetyl)-l-lysine: A novel organometallic nuclease

The synthesis of a new unnatural amino acid, Nα-Nε-(ferrocene-1-acetyl)-l-lysine, was achieved by coupling a ferroceneacetic acid molecule onto the side chain amine of a lysine. The structure of the compound provides options for inco

METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE

Disclosed herein are methods of preparing N6-((2-azidoethoxy)carbonyl)lysine, N6-((2-azidoethoxy)carbonyl)-L-lysine, and N6-((2-azidoethoxy)carbonyl)-D-lysine. Also disclosed herein are the compounds tert-butyl N2-(tert-butoxycarbonyl)-N6-((2-chloroethoxy)carbonyl)-L-lysinate and tertbutyl N6-((2-azidoethoxy)carbonyl)-N2-(tert-butoxycarbonyl)-L-lysinate, and uses thereof.

Antitumor agents 7. Synthesis, antiproliferative activity and molecular modeling of new L-lysine-conjugated pyridophenoxazinones as potent DNA-binding ligands and topoisomerase IIα inhibitors

A series of L-lysine-conjugated pyridophenoxazinones 2–5 and 2′-5′ were designed and synthesized for developing compounds with multimodal anticancer potentialities. All compounds inhibited the proliferation of a panel of human liquid and solid neoplastic